GLP-1 microdosing
Using sub-therapeutic GLP-1 doses, often marketed by compounders. Limited evidence.
Microdosing means using doses below the trial-validated therapeutic range, sometimes marketed as gentler or cheaper. Evidence for efficacy at microdoses is limited; trial weight-loss figures come from full titrated doses.